Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, today announced the appointment of three ...

NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...

That's why we generated Xcell TM HEK293 complemented with advanced analytics to guarantee the highest quality AAV for transformative therapeutic solutions." Igor Fisch, CEO and co-founder of ...

Abeona Therapeutics (NASDAQ:ABEO – Get Free Report) is anticipated to release its earnings data before the market opens on Monday, March 17th. Analysts expect Abeona Therapeutics to post earnings of ...

(MENAFN- GlobeNewsWire - Nasdaq) LAUSANNE, Switzerland, March 05, 2025 (GLOBE NEWSWIRE ... analytics to guarantee the highest quality AAV for transformative therapeutic solutions.” ...

Fintel reports that on March 5, 2025, Oppenheimer initiated coverage of Abeona Therapeutics (NasdaqCM:ABEO) with a Outperform ...

Zeitler likely won't break the bank in terms of years or AAV, making it a viable option for Detroit. Onwuzurike stayed fully ...

After a strong start to the 2024 season, the New Orleans Saints faltered down the stretch as their poor depth could not ...

Phase 1 Dose Expansion Initiated for FT819 Off-the-Shelf CAR T-cell Product Candidate with Fludarabine-free Conditioning in ...

Mathieu Olivier has set career highs, bolstered his fighting reputation and earned a six-year deal from the Blue Jackets worth $18 million.

Follow along here during the entire final day of NHL trade action for news and analysis of all the biggest moves.